MedTrace Logo

High-Dose Intravenous Lipid for Very Preterm or Very Low Birth Weight Infants Effects on Growth

NCT06909929 · Status: ENROLLING_BY_INVITATION · Phase: NA · Type: INTERVENTIONAL · Enrollment: 70

Last updated 2025-04-04

No results posted yet for this study

Summary

This is a RCT study conducted in Cipto Mangunkusumo Hospital in very preterm infants. The investigators compared early intravena lipid start with 2 gram per body weight and 1 gram per body weight and observed the time to reach birth weight.

Conditions

  • Very Preterm Birth

Interventions

DIETARY_SUPPLEMENT

Lipid IV 2 g

This group will get 2 g of lipid IV in the early 24 hours of life

DIETARY_SUPPLEMENT

lipid IV 1 gram

This group will get 1 g of lipid IV in the early 24 hours of life

Sponsors & Collaborators

  • Indonesia University

    lead OTHER

Principal Investigators

  • Putri MT Marsubrin, MD, PhD · Cipto Mangunkusumo Hospital, Jakarta, Central Jakarta 10430

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Max Age
32 Weeks
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-01-16
Completion
2025-03-26

Countries

  • Indonesia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06909929 on ClinicalTrials.gov